Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe
K
K
Department of Urology, Tokyo Women's Medical College, Japan.
Ishikawa
N
N
Tokumoto
T
T
Takahashi
K
K
Kanematsu
A
A
Kitani
R
R
Fuchinoue
S
S
Oshima
T
T
Yagisawa
T
T
Toma
H
H
D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone